$DOV

Is Dover Stock Underperforming the Dow?

Dover Corp. (DOV) has underperformed rival Eaton Corp. (ETN) year-to-date but outperformed over 52 weeks. Analysts give DOV a 'Moderate Buy' rating with a $244.94 mean price target, implying 29.5% upside. DOV is in the specialty industrial machinery industry.

Original reporting
Published Sep 16, 2026, 9:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 9:47 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Is Dover Stock Underperforming the Dow? — source image
Decision brief

The 30-second read

$DOVNeutralLow
01

Why it matters

The piece reiterates existing analyst sentiment and price targets, offering little new actionable insight.

02

Market read

Low relevance; primarily a recap of analyst coverage.

03

What to watch

Potential supply‑chain constraints or macro‑economic headwinds are not discussed.

Relevance 4/10Novelty 2/10Timing: post‑market commentary

Background

Dover (DOV) and Eaton (ETN) are peers in the specialty industrial machinery space.

Company-level read

Ticker impact

$DOVNeutralMedium confidence
Context

Analysts note a consensus Moderate Buy rating and a $244.94 price target implying 29.5% upside.

Expected impact

Limited short‑term impact; price may drift toward target over weeks.

Evidence & confidence

The article provides only analyst price target and rating without new corporate event.

Market effects

None beyond routine analyst coverage of industrial machinery sector.

No regional effect noted.

Minimal; article is US‑focused and does not affect broader markets.

Counterpoint

Without a fresh catalyst, the price target may be overly optimistic.

Key entities

  • Dover

    Subject of the article; industrial machinery maker.

Related articles

$OTISMedAI 8/10

General Industrial Machinery Stocks Q2 In Review: Otis (NYSE:OTIS) Vs Peers

General industrial machinery stocks reported strong Q2 revenues, beating estimates by 2.6%. Otis (OTIS) reported $3.86B revenue, up 7.3% YoY. Columbus McKinnon (CMCO) saw 125% revenue growth. Albany (AIN) missed estimates, down 3.1%. Dover (DOV) missed expectations by 0.8%. JBT Marel (JBTM) met revenue expectations but missed EPS guidance. Stocks in the sector are down 5.5% on average since earnings.

$DOVMed

OPW acquires cryogenic expertise

Dover Corp. (DOV) agreed to acquire Leistung Engineering, an India-based cryogenic valve manufacturer, for its OPW Fluid Transfer Solutions segment. Leistung has shown double-digit growth and will serve as a strategic hub for Dover in India's growing LNG market. The deal is expected to close in Q4, with terms undisclosed. Dover reported $8B in annual revenue.

$DOVMedAI 8/10

Dover to Acquire Leistung, Expand Manufacturing Footprint and Cryogenic Offerings

Dover Corporation (NYSE: DOV) will acquire Leistung Engineering Pvt. Ltd., a cryogenic valve manufacturer, to expand its Clean Energy & Fueling segment. Leistung's Indian facility will serve as a strategic manufacturing hub. The deal is expected to close in Q4, with terms undisclosed. Dover reported $8B in annual revenue. The acquisition aims to boost Dover's presence in the Indian market and global cryogenic solutions.

$DOVMed

Dover To Acquire Cloeren And Expand Polymer Processing Portfolio

Dover (according to the company) signed an agreement to acquire Cloeren, a maker of extrusion T-dies and feedblocks for polymer and plastics processing. Terms were not disclosed. The deal is expected to close in Q3 2026, subject to conditions, and Cloeren will join Dover’s MAAG unit in the Pumps and Process Solutions segment. Dover has $8B+ annual revenue.

$DOVMedAI 8/10

Dover to Acquire Cloeren, a Leading Manufacturer of T-dies and Feedblocks

Dover Corporation (NYSE: DOV) said it signed a definitive agreement to acquire Cloeren Incorporated, adding extrusion T-dies and feedblocks to the MAAG business unit in Dover’s Pumps & Process Solutions segment. Cloeren will be based in Orange, Texas, with other sites in Texas, Wisconsin, and Austria. The deal is expected to close in Q3; terms were not disclosed.